The Importance of Genetic Testing in the Diagnosis and Management of Peripartum Cardiomyopathy: A Case Study

By afschroeder • April 2, 2026

D'Costa ZU, Wong EK, Zhang M, Fishbein GA, Wang J, Kamath M, Shahandeh N. The Importance of Genetic Testing in the Diagnosis and Management of Peripartum Cardiomyopathy: A Case Study. ESC Heart Fail. 2026 Apr 1:xvag090. doi: 10.1093/eschf/xvag090. Epub ahead of print. PMID: 41920946.

Tags: arrhythmogenic cardiomyopathy, Cardiology/Epi, Desmoplakin, General Internal Medicine, Genetic testing, Peripartum cardiomyopathy, Publications, Resident, VA-ECMO

Related Posts

Blood Pressure Genetic Risk and Incident Hypertension at 2 to 7 Years Post Partum

Hemeryck J, De Moor N, Ezzat D, Khan RR, Vandergrift N, Levine LD, Rouse C, Theilen LH, Bairey Merz CN, Yee LM, Chung J, Bello[...]

Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction

Jacobs JA, Greene T, Vanneman ME, Kean J, Carter SJ, Shah KS, Pandey A, Derington CG, Zheutlin AR, Fang J, Stehlik J, Fonarow GC, Bress[...]

The Patient Post

Calais J, Czernin J. The Patient Post. J Nucl Med. 2026 Apr 1;67(4):493. doi: 10.2967/jnumed.126.272317. PMID: 41922019.